Literature DB >> 11073992

Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain.

C Lindon1, O Albagli, P Domeyne, D Montarras, C Pinset.   

Abstract

Transcription factors Myf5 and MyoD play critical roles in controlling myoblast identity and differentiation. In the myogenic cell line C2, we have found that Myf5 expression, unlike that of MyoD, is restricted to cycling cells and regulated by proteolysis at mitosis. In the present study, we have examined Myf5 proteolysis through stable transfection of myogenically convertible U20S cells with Myf5 derivatives under the control of a tetracycline-sensitive promoter. A motif within the basic helix-loop-helix domain of Myf5 (R93 to Q101) resembles the "destruction box" characteristic of substrates of mitotic proteolysis and thought to be recognized by the anaphase-promoting complex or cyclosome (APC). Mutation of this motif in Myf5 stabilizes the protein at mitosis but does not affect its constitutive turnover. Conversely, mutation of a serine residue (S158) stabilizes Myf5 in nonsynchronized cultures but not at mitosis. Thus, at least two proteolytic pathways control Myf5 levels in cycling cells. The mitotic proteolysis of Myf5 is unlike that which has been described for other destruction box-dependent substrates: down-regulation of Myf5 at mitosis appears to precede that of known targets of the APC and is not affected by a dominant-negative version of the ubiquitin carrier protein UbcH10, implicated in the APC-mediated pathway. Finally, we find that induction of Myf5 perturbs the passage of cells through mitosis, suggesting that regulation of Myf5 levels at mitosis may influence cell cycle progression of Myf5-expressing muscle precursor cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073992      PMCID: PMC86547          DOI: 10.1128/MCB.20.23.8923-8932.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD.

Authors:  M Horwitz
Journal:  Exp Cell Res       Date:  1996-07-10       Impact factor: 3.905

2.  The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.

Authors:  M Brandeis; T Hunt
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

3.  Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates.

Authors:  R W King; M Glotzer; M W Kirschner
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

4.  Displacement of sequence-specific transcription factors from mitotic chromatin.

Authors:  M A Martínez-Balbás; A Dey; S K Rabindran; K Ozato; C Wu
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

5.  A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.

Authors:  R W King; J M Peters; S Tugendreich; M Rolfe; P Hieter; M W Kirschner
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

6.  Myf5, MyoD, myogenin and MRF4 myogenic derivatives of the embryonic mesenchymal cell line C3H10T1/2 exhibit the same adult muscle phenotype.

Authors:  F Auradé; C Pinset; P Chafey; F Gros; D Montarras
Journal:  Differentiation       Date:  1994-02       Impact factor: 3.880

7.  Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor.

Authors:  S L Holloway; M Glotzer; R W King; A W Murray
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

8.  Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation.

Authors:  W Gu; J W Schneider; G Condorelli; S Kaushal; V Mahdavi; B Nadal-Ginard
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

9.  The cellular content of Cdc25p, the Ras exchange factor in Saccharomyces cerevisiae, is regulated by destabilization through a cyclin destruction box.

Authors:  T Kaplon; M Jacquet
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

10.  WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

Authors:  C Englert; X Hou; S Maheswaran; P Bennett; C Ngwu; G G Re; A J Garvin; M R Rosner; D A Haber
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  14 in total

1.  Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program.

Authors:  Mounia Lagha; Jay D Kormish; Didier Rocancourt; Marie Manceau; Jonathan A Epstein; Kenneth S Zaret; Frédéric Relaix; Margaret E Buckingham
Journal:  Genes Dev       Date:  2008-07-01       Impact factor: 11.361

2.  P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype.

Authors:  Desi Pan; Xiaoning Zhe; Sandhya Jakkaraju; Gregory A Taylor; Lucia Schuger
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

3.  Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.

Authors:  Shu-Ching Huang; Anyu Zhou; Dan T Nguyen; Henry S Zhang; Edward J Benz
Journal:  J Biol Chem       Date:  2016-10-25       Impact factor: 5.157

4.  The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny.

Authors:  Kenneth Day; Gabi Shefer; Andrew Shearer; Zipora Yablonka-Reuveni
Journal:  Dev Biol       Date:  2010-01-15       Impact factor: 3.582

5.  Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.

Authors:  Lionel A J Tintignac; Valentina Sirri; Marie Pierre Leibovitch; Yann Lécluse; Maria Castedo; Didier Metivier; Guido Kroemer; Serge A Leibovitch
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

6.  Ubiquitylation on canonical and non-canonical sites targets the transcription factor neurogenin for ubiquitin-mediated proteolysis.

Authors:  Jonathan M D Vosper; Gary S McDowell; Christopher J Hindley; Christelle S Fiore-Heriche; Romana Kucerova; Ian Horan; Anna Philpott
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

7.  A distinct profile of myogenic regulatory factor detection within Pax7+ cells at S phase supports a unique role of Myf5 during posthatch chicken myogenesis.

Authors:  Kenneth Day; Bruce Paterson; Zipora Yablonka-Reuveni
Journal:  Dev Dyn       Date:  2009-04       Impact factor: 3.780

8.  Regulation of neurogenin stability by ubiquitin-mediated proteolysis.

Authors:  Jonathan M D Vosper; Christelle S Fiore-Heriche; Ian Horan; Kate Wilson; Helen Wise; Anna Philpott
Journal:  Biochem J       Date:  2007-10-15       Impact factor: 3.857

9.  Ataxin-3 plays a role in mouse myogenic differentiation through regulation of integrin subunit levels.

Authors:  Maria do Carmo Costa; Fernanda Bajanca; Ana-João Rodrigues; Ricardo J Tomé; Garry Corthals; Sandra Macedo-Ribeiro; Henry L Paulson; Elsa Logarinho; Patrícia Maciel
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells.

Authors:  Chung-Il An; Edward Ganio; Nobuko Hagiwara
Journal:  Skelet Muscle       Date:  2013-05-10       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.